PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Clinical trials for PRIMARY IMMUNODEFICIENCY DISEASES (PID) explained in plain language.
Never miss a new study
Get alerted when new PRIMARY IMMUNODEFICIENCY DISEASES (PID) trials appear
Sign up with your email to follow new studies for PRIMARY IMMUNODEFICIENCY DISEASES (PID), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test gene fix and drug combo for rare immune diseases in the lab
Knowledge-focused Recruiting nowThis study uses blood samples from 20 adults with primary immunodeficiency diseases to see how JAK inhibitors affect the immune system and whether a gene therapy approach can correct genetic faults. The goal is to gather knowledge that could lead to better treatments. Participant…
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Phase: NA • Sponsor: prof. dr. Rik Schrijvers • Aim: Knowledge-focused
Last updated May 15, 2026 11:57 UTC
-
Researchers dig into records to see how safe cuvitru is for immune deficiency
Knowledge-focused Recruiting nowThis study looks back at medical records of about 100 people in Japan with primary immunodeficiency who received Cuvitru. The goal is to track serious side effects like allergic reactions, blood clots, and meningitis. No new treatments are given—just a review of existing data to …
Matched conditions: PRIMARY IMMUNODEFICIENCY DISEASES (PID)
Sponsor: Takeda • Aim: Knowledge-focused
Last updated May 06, 2026 16:03 UTC